Revisión de las fórmulas magistrales (medicamentos individualizados) de mayor interés en dermatología pediátrica

Abarca Lachén, E. ; Hernando Martínez, P. ; Gilaberte Calzada, Y. (Universidad de Zaragoza)

Resumen: The administration of appropriate doses of active ingredients and excipients is crucial for achieving desired treatment outcomes in pediatric dermatology. A number of factors need to be considered, including the characteristics of the lesion, the patient, and the drug. An additional challenge in pediatric settings is the limited number of commercially available formulations suitable for use in children. Drug compounding, which is the preparation of medications tailored to the needs of individual patients, is a good alternative for pediatric populations for a number of reasons. Using a customized compound, the clinician can prescribe formulations that contain the optimal dose of the active ingredients within acceptable limits and the most suitable vehicle and formulation components. Compounding can also be used to combine several active ingredients in a single medication and even adapt the vehicle to the characteristics of the lesion and the needs of the patient. The pharmaceutical formulations described in this review are based on extensive clinical experience and can be customized to meet individual needs. is the preparation of medications tailored to the needs of individual patients, is a good alternative for pediatric populations for a number of reasons. Using a customized compound, the clinician can prescribe formulations that contain the optimal dose of the active ingredients within acceptable limits and the most suitable vehicle and formulation components. Compounding can also be used to combine several active ingredients in a single medication and even adapt the vehicle to the characteristics of the lesion and the needs of the patient. The pharmaceutical formulations described in this review are based on extensive clinical experience and can be customized to meet individual needs.

Idioma: Español

DOI: 10.1016/j.ad.2020.11.006

Año: 2021

Publicado en: Actas Dermo-Sifiliograficas 112, 4 (2021), 302-313
ISSN: 0001-7310

Factor impacto CITESCORE: 1.2 - Medicine (Q3)

Factor impacto SCIMAGO: 0.279 - Pathology and Forensic Medicine (Q3) - Dermatology (Q3)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Dermatología (Dpto. Medicina, Psiqu. y Derm.)